GLP-1 drugs: what Indiana Medicaid paid

Q: Does a paid prescription mean Indiana Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Indiana Medicaid shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Indiana Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Indiana Medicaid’s payment record shows

In 2026Q1, the product Indiana Medicaid paid for most often was Ozempic®, at 26,018 prescriptions¹⁹ of the 35,610 to 35,772^{1,7,13,19,25,37,43} across all 8 products, or 73 percent of the published count.

Indiana Medicaid itself reimbursed at least $39,614,988 for these products in the quarter, about $1,113 per prescription. Pharmacies were paid $39,953,946 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,296.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Indiana Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Indiana Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Indiana Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Indiana Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both4,033 managed care, 197 direct	at least 4,230¹	12%	$4,459,878	$4,481,889	$1,054
tirzepatideMounjaro®	Both3,021 managed care, 155 direct	3,176⁷	9%	$3,614,593	$3,703,743	$1,138
semaglutideWegovy®	Both1,392 managed care, 129 direct	at least 1,521¹³	4%	$1,971,913	$2,010,153	$1,296
semaglutideOzempic®	Both24,799 managed care, 1,219 direct	at least 26,018¹⁹	73%	$29,184,196	$29,369,463	$1,122
semaglutideRybelsus®	Both173 managed care, 17 direct	at least 190²⁵	<1%	$220,043	$224,333	$1,158
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	at least 64³⁷	<1%	$45,453	$45,453	$710
liraglutideliraglutide (generic)	Both	at least 393⁴³	1%	$118,912	$118,912	$303

Indiana Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 26.6 to 26.7 prescriptions per thousand people enrolled in Indiana Medicaid, on an average of 1,337,300 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 22 of the 168 product-quarters it holds a row for here, which is 13 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Indiana Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Indiana Medicaid paid for each product, quarter by quarter

Prescriptions Indiana Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld4 of 4 product codes withheld	at least 456 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$483,776 paid	at least 1,878 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$1,866,418 paid	at least 3,118 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$3,214,036 paid	at least 4,230 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$4,459,878 paid
tirzepatideMounjaro®range 3,142 to 6,841, up 34 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	at least 12 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld¹¹At least$10,740 paid	at least 788 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$754,014 paid	at least 2,675 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$2,586,451 paid	at least 4,747 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$4,843,086 paid	6,203 paid prescriptions in the quarter (2023Q2)¹⁰Count$6,301,443 paid	6,630 paid prescriptions in the quarter (2023Q3)¹⁰Count$6,932,137 paid	at least 6,317 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$6,799,167 paid	6,146 paid prescriptions in the quarter (2024Q1)⁹Count$6,892,265 paid	6,841 paid prescriptions in the quarter (2024Q2)⁹Count$7,649,073 paid	6,618 paid prescriptions in the quarter (2024Q3)⁹Count$7,415,271 paid	at least 5,453 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$6,217,262 paid	4,039 paid prescriptions in the quarter (2025Q1)⁸Count$4,663,905 paid	at least 3,352 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$3,705,424 paid	3,176 paid prescriptions in the quarter (2025Q3)⁸Count$3,540,457 paid	3,142 paid prescriptions in the quarter (2025Q4)⁸Count$3,588,072 paid	3,176 paid prescriptions in the quarter (2026Q1)⁷Count$3,614,593 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld6 of 6 product codes withheld	at least 126 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$160,903 paid	at least 303 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$391,330 paid	at least 468 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$624,342 paid	at least 592 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$792,243 paid	at least 768 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$1,004,690 paid	at least 916 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$1,203,539 paid	1,021 paid prescriptions in the quarter (2025Q4)¹⁴Count$1,337,431 paid	at least 1,521 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$1,971,913 paid
semaglutideOzempic®	at least 8,422 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$7,519,985 paid	at least 10,061 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$9,076,113 paid	at least 10,859 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$9,981,839 paid	at least 11,796 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$10,675,067 paid	at least 13,417 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$12,714,717 paid	at least 16,400 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$15,587,826 paid	at least 17,423 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$16,503,311 paid	at least 17,475 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$16,266,682 paid	at least 22,488 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$21,570,799 paid	at least 27,377 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$26,314,275 paid	at least 27,593 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$26,789,705 paid	at least 23,992 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$23,491,380 paid	at least 29,721 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$30,477,976 paid	at least 33,068 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$34,284,192 paid	at least 34,538 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$36,097,547 paid	at least 34,966 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$37,084,567 paid	at least 35,374 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$38,358,248 paid	at least 35,544 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$37,472,288 paid	at least 33,843 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$36,035,681 paid	at least 30,778 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$33,171,863 paid	at least 26,018 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$29,184,196 paid
semaglutideRybelsus®	at least 466 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$403,500 paid	at least 736 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$631,476 paid	at least 851 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$775,119 paid	at least 973 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$889,691 paid	at least 1,115 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$1,097,560 paid	at least 1,409 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$1,358,164 paid	at least 1,562 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$1,510,302 paid	at least 1,689 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$1,677,376 paid	at least 1,927 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$1,991,145 paid	at least 1,971 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$2,071,044 paid	at least 1,690 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$1,878,518 paid	at least 1,060 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$1,272,758 paid	at least 962 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$1,244,688 paid	at least 895 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$1,183,431 paid	at least 704 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$922,817 paid	at least 531 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$713,259 paid	at least 355 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$473,690 paid	at least 246 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$283,201 paid	at least 201 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$224,530 paid	at least 178 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$201,018 paid	at least 190 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$220,043 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³³Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 90 to 5,506	5,432 paid prescriptions in the quarter (2021Q1)⁴²Count$5,249,310 paid	5,506 paid prescriptions in the quarter (2021Q2)⁴²Count$5,374,291 paid	5,329 paid prescriptions in the quarter (2021Q3)⁴²Count$5,120,732 paid	4,519 paid prescriptions in the quarter (2021Q4)⁴²Count$4,319,880 paid	3,305 paid prescriptions in the quarter (2022Q1)⁴¹Count$3,245,666 paid	2,342 paid prescriptions in the quarter (2022Q2)⁴¹Count$2,262,037 paid	2,301 paid prescriptions in the quarter (2022Q3)⁴¹Count$2,234,057 paid	2,094 paid prescriptions in the quarter (2022Q4)⁴¹Count$2,005,130 paid	2,009 paid prescriptions in the quarter (2023Q1)⁴⁰Count$2,002,133 paid	1,832 paid prescriptions in the quarter (2023Q2)⁴⁰Count$1,797,567 paid	1,352 paid prescriptions in the quarter (2023Q3)⁴⁰Count$1,395,733 paid	1,419 paid prescriptions in the quarter (2023Q4)⁴⁰Count$1,415,169 paid	1,202 paid prescriptions in the quarter (2024Q1)³⁹Count$947,669 paid	932 paid prescriptions in the quarter (2024Q2)³⁹Count$721,305 paid	at least 343 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$246,289 paid	at least 240 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$179,118 paid	at least 244 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$142,438 paid	at least 124 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$71,892 paid	at least 92 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³⁸At least$55,398 paid	90 paid prescriptions in the quarter (2025Q4)³⁸Count$56,821 paid	at least 64 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$45,453 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	at least 471 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$279,844 paid	at least 499 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$302,873 paid	at least 226 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$126,087 paid	at least 266 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$103,498 paid	at least 396 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$129,650 paid	at least 419 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$131,825 paid	at least 393 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$118,912 paid

What this page cannot tell you

Whether Indiana Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Indiana in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, IN
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state IN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1386"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, IN
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state IN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "967"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, IN
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state IN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, IN
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state IN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like ZEPBOUND%, state IN, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, IN
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state IN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like ZEPBOUND%, state IN, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, IN
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state IN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like ZEPBOUND%, state IN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, IN
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state IN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "631"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, IN
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state IN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 7", "suppression_used": "false", "number_of_prescriptions": "816"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, IN
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state IN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1804"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, IN
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state IN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "2014"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, IN
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state IN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1022"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, IN
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state IN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like MOUNJARO%, state IN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, IN
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state IN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "452"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, IN
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state IN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 0.5", "suppression_used": "false", "number_of_prescriptions": "201"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, IN
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state IN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "143"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, IN
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state IN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1.7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, IN
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state IN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "WEGOVY 1.7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, IN
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state IN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, IN
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state IN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "9148"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, IN
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state IN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "13143"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, IN
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state IN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "13850"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, IN
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state IN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "12217"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, IN
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state IN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "8574"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, IN
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state IN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "6244"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, IN
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state IN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "68"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, IN
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state IN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "162"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, IN
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state IN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "393"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, IN
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state IN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "939"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, IN
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state IN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "821"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, IN
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state IN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "431"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, IN
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state IN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like SAXENDA%, state IN, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, IN
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state IN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, IN
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state IN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, IN
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state IN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, IN
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state IN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like SAXENDA%, state IN, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, IN
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state IN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like SAXENDA%, state IN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, IN
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state IN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "33"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, IN
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state IN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "185"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, IN
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state IN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "719"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, IN
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state IN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1270"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, IN
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state IN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "2140"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, IN
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state IN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "3791"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, IN
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state IN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "116"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, IN
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state IN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "160"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, IN
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state IN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "266"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, IN
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state IN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like LIRAGLUTID%, state IN, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, IN
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state IN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like LIRAGLUTID%, state IN, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, IN
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state IN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IN", "product_name": "product_name like LIRAGLUTID%, state IN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 38 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 10 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Indiana Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.